Oral compound for Gaucher Disease promising »
Posted By junda 5 months ago in StyleGenzyme reported today that a preliminary analysis of data from an ongoing open-label Phase 2 clinical trial of its investigational oral therapy Genz-112638 showed that the compound produced a meaningful impact on key clinical manifestations of Gaucher disease.
Read Full Story at thaihealth.net »
Submitted By:
junda
Hi this is another side of my world ,I have graduated with medical degree with first class honor in Thai university ,and enter internal medicine ...
Related Articles:
Why not submit a story?
Add a Comment
Please keep your comments relevant to this story.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.